A clinical trial to compare the safety and effectiveness of ipatasertib plus palbociclib and fulvestrant versus a placebo plus palbociclib and fulvestrant in people with breast cancer

A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer

Cancer
Breast Cancer
Breast Cancer Er-Positive

Results
Download
Print

Study results

LPS CO41012 IPATunity150 Final Results July 2024 English (PDF, 1.0 MB)

LPS CO41012 IPATunity150 Final Results July 2024 Spain Spanish (PDF, 0.6 MB)

LPS CO41012 IPATunity150 Final Results July 2024 Brazil Portuguese (PDF, 0.3 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A clinical trial to compare the safety and effectiveness of ipatasertib plus palbociclib and fulvestrant versus a placebo plus palbociclib and fulvestrant in people with breast cancer

Study results

LPS CO41012 IPATunity150 Final Results July 2024 English (PDF, 1.0 MB)

LPS CO41012 IPATunity150 Final Results July 2024 Spain Spanish (PDF, 0.6 MB)

LPS CO41012 IPATunity150 Final Results July 2024 Brazil Portuguese (PDF, 0.3 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A clinical trial to compare the safety and effectiveness of ipatasertib plus palbociclib and fulvestrant versus a placebo plus palbociclib and fulvestrant in people with breast cancer

For the latest version of this information please go to www.forpatients.roche.com